AstraZeneca (LON:AZN) Earns Hold Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reiterated their hold rating on shares of AstraZeneca (LON:AZN) in a report published on Tuesday, MarketBeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has a £110 ($144.64) price target on the biopharmaceutical company’s stock.

A number of other research firms have also commented on AZN. Jefferies Financial Group raised their price objective on shares of AstraZeneca from GBX 71 ($0.93) to GBX 74 ($0.97) and gave the company a hold rating in a research note on Tuesday, July 2nd. Berenberg Bank reiterated a buy rating and set a £150 ($197.24) price objective on shares of AstraZeneca in a research note on Monday. JPMorgan Chase & Co. reiterated an overweight rating on shares of AstraZeneca in a research note on Tuesday, June 4th. Citigroup reiterated a buy rating on shares of AstraZeneca in a research note on Tuesday, May 28th. Finally, Shore Capital restated a buy rating on shares of AstraZeneca in a research report on Thursday, July 25th. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of Moderate Buy and an average target price of £105.53 ($138.77).

AstraZeneca Price Performance

Shares of LON:AZN opened at £125.40 ($164.89) on Tuesday. AstraZeneca has a 52 week low of GBX 9,461 ($124.40) and a 52 week high of £133.88 ($176.04). The company has a current ratio of 0.89, a quick ratio of 0.59 and a debt-to-equity ratio of 84.97. The firm has a market capitalization of £194.37 billion, a P/E ratio of 4,019.23, a PEG ratio of 1.08 and a beta of 0.15. The firm’s 50 day moving average is £125.59 and its two-hundred day moving average is £117.93.

AstraZeneca Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Monday, September 9th. Investors of record on Thursday, August 8th will be paid a GBX 77.60 ($1.02) dividend. This represents a yield of 0.64%. The ex-dividend date is Thursday, August 8th. AstraZeneca’s dividend payout ratio is 7,500.00%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.